Literature DB >> 9000416

A molecular view of proximal tubular inorganic phosphate (Pi) reabsorption and of its regulation.

H Murer1, J Biber.   

Abstract

In recent years, two mammalian proximal tubular brush border membrane Na/Pi cotransporters (types I and II) have been structurally identified by expression cloning techniques. Oocyte expression studies have shown that only the transport characteristics of the type II transporter correspond to the well-known properties of proximal tubular brush border membrane of Pi transport. In studies on physiological regulation by hormonal and non-hormonal factors a direct involvement and determining role of the type II transporter has been documented. Most interestingly, specific membrane retrieval/insertion phenomena participate in acute (minutes/hours) adjustments of brush border membrane Na/Pi cotransport rates; for chronic (hours/days) alterations also specific resynthesis/degradation processes participate. In pathophysiological alterations (e.g. in X-linked hypophosphataemia and in heavy metal-induced nephrotoxicity) the expression of the type II Na/Pi cotransporters is reduced and explains the observed phosphaturia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9000416     DOI: 10.1007/s004240050292

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  16 in total

1.  Effects of Npt2 gene ablation and low-phosphate diet on renal Na(+)/phosphate cotransport and cotransporter gene expression.

Authors:  H M Hoag; J Martel; C Gauthier; H S Tenenhouse
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

Review 2.  Emerging roles of transporter-PDZ complexes in renal proximal tubular reabsorption.

Authors:  J Biber
Journal:  Pflugers Arch       Date:  2001-10       Impact factor: 3.657

3.  Effects of dietary Pi on the renal Na+-dependent Pi transporter NaPi-2 in thyroparathyroidectomized rats.

Authors:  F Takahashi; K Morita; K Katai; H Segawa; A Fujioka; T Kouda; S Tatsumi; T Nii; Y Taketani; H Haga; S Hisano; Y Fukui; K I Miyamoto; E Takeda
Journal:  Biochem J       Date:  1998-07-01       Impact factor: 3.857

4.  The Na+-phosphate cotransport system (NaPi-II) with a cleaved protein backbone: implications on function and membrane insertion.

Authors:  B Kohl; C A Wagner; B Huelseweh; A E Busch; A Werner
Journal:  J Physiol       Date:  1998-04-15       Impact factor: 5.182

5.  Amino acids involved in sodium interaction of murine type II Na(+)-P(i) cotransporters expressed in Xenopus oocytes.

Authors:  C de La Horra; N Hernando; I Forster; J Biber; H Murer
Journal:  J Physiol       Date:  2001-03-01       Impact factor: 5.182

6.  Properties of the mutant Ser-460-Cys implicate this site in a functionally important region of the type IIa Na(+)/P(i) cotransporter protein.

Authors:  G Lambert; I C Forster; G Stange; J Biber; H Murer
Journal:  J Gen Physiol       Date:  1999-11       Impact factor: 4.086

7.  Rapid downregulation of rat renal Na/P(i) cotransporter in response to parathyroid hormone involves microtubule rearrangement.

Authors:  M Lötscher; Y Scarpetta; M Levi; N Halaihel; H Wang; H K Zajicek; J Biber; H Murer; B Kaissling
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

8.  Essential cysteine residues of the type IIa Na+/Pi cotransporter.

Authors:  Katja Köhler; Ian C Forster; Gerti Stange; Jürg Biber; Heini Murer
Journal:  Pflugers Arch       Date:  2003-03-26       Impact factor: 3.657

9.  Characterization of a murine type II sodium-phosphate cotransporter expressed in mammalian small intestine.

Authors:  H Hilfiker; O Hattenhauer; M Traebert; I Forster; H Murer; J Biber
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

10.  Intravenous phosphate in the intensive care unit: more aggressive repletion regimens for moderate and severe hypophosphatemia.

Authors:  Thierry Charron; Francis Bernard; Yoanna Skrobik; Nathalie Simoneau; Nadine Gagnon; Martine Leblanc
Journal:  Intensive Care Med       Date:  2003-07-05       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.